The journal is devoted to the advancement of research, delivery, and exchange of scientific information associated with human health and biomedical sciences. jbarbiomed is committed to timeliness, transparency, and adherence to the ethical and editorial standards set out by the International Committee of Medical Journal Editors (ICMJE) and the Committee on Publication Ethics (COPE).
jbarbiomed is dedicated to the principles of Open Access, ensuring that scientific knowledge is freely available to all, without financial, legal, or technical barriers. All articles are accessible online immediately upon publication, without subscription fees or access restrictions.
Open Access (OA) refers to the unrestricted availability of peer-reviewed scholarly research on the internet. Users may read, download, share, print, copy, distribute, link to, and text-mine the full content of articles without seeking permission, provided proper attribution is given to the original authors and source.
jbarbiomed adheres to BOAI and follows the Gold Open Access model:
Published content is preserved for long-term access through LOCKSS and CLOCKSS, ensuring articles remain accessible even if the journal itself ceases publication in the future.
Authors retain full copyright of their published work. All articles are published under the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted reuse, adaptation, and distribution (including commercial use), provided proper attribution is given. Self-archiving of any version of the article (submitted, accepted, or published) is permitted without embargo. See Section 5 (Copyright Policy) for the full terms.
All manuscripts submitted to jbarbiomed undergo double-blind peer review:
jbarbiomed follows COPE guidance on handling complaints and appeals.
Appeal of a rejection decision: Authors who believe a rejection was based on a misunderstanding, an error, or a biased/incomplete review may submit a written appeal to the Editor-in-Chief, addressing the specific concerns raised. The Editor-in-Chief may, at their discretion, seek an additional independent reviewer before making a final decision. Only one appeal per manuscript will be considered; the decision following appeal is final.
Complaints about the editorial process: Concerns about the conduct of an editor, reviewer, or the handling of a manuscript (as distinct from disagreement with the scientific decision) may be raised in writing to the Editor-in-Chief. If the complaint concerns the Editor-in-Chief directly, it should instead be addressed, in writing, to the Editorial Board (see the Editorial Team page), which will review the matter independently of the Editor-in-Chief. All complaints will be acknowledged and investigated following COPE’s complaint-handling guidance.
Authors are responsible for ensuring the originality of their manuscript and for appropriately citing and quoting others’ work. All submissions are screened using plagiarism-detection software before entering peer review.
Submission of a manuscript to jbarbiomed signifies that the work is original, has not been previously published, and is not under review elsewhere, and that authors have secured all necessary permissions for any third-party content (figures, tables, excerpts) reproduced from other sources.
Authors retain full copyright of their published work. Upon acceptance, authors sign a License to Publish Agreement, granting jbarbiomed the right to publish and distribute the article, and granting the public a license to reuse it under the terms of CC BY 4.0. This license permits:
provided that (a) proper attribution is given to the original authors, (b) the original source and citation are clearly indicated, and (c) the integrity of the article is preserved (i.e., it is not misrepresented or altered in a misleading way).
Authors publishing in jbarbiomed retain the right to:
In turn, authors grant jbarbiomed the right to publish and disseminate the article online and to be acknowledged as the original publisher of record.
All content is Open Access and available for reuse without prior permission from the publisher. Third parties may share, reproduce, or modify the content, including for commercial or educational use, provided that (1) the original authors and publication source are clearly credited, and (2) the work is not misrepresented or altered in a misleading way.
jbarbiomed upholds strict ethical standards for research involving human subjects. All studies must comply with the Declaration of Helsinki (current version: as revised at the 64th WMA General Assembly, Fortaleza, Brazil, 2013, with the amendment adopted by the WMA General Assembly in October 2024) and internationally recognized guidelines on human research ethics.
Authors must ensure the following:
The manuscript should include a declaration such as:
“All procedures involving human participants were conducted in accordance with the ethical standards of the institutional and/or national research committee and with the Declaration of Helsinki, as revised in 2013 (and amended in 2024).”
Authors must also confirm: “Informed consent was obtained from all individuals included in the study.” If informed consent was not possible or was waived, a clear justification and the name of the body granting the waiver must be provided. Upon editorial request, authors must submit a copy of the ethics committee’s approval letter for verification.
Studies involving animals must comply with the National Research Council’s Guide for the Care and Use of Laboratory Animals or an equivalent institutional/national guideline, and should be reported following the ARRIVE 2.0 guidelines.
Authors must: 1. Obtain prior written approval from their institutional animal care and use committee (IACUC) or equivalent body. 2. Clearly describe ethical compliance in the manuscript, including animal care protocols, experimental procedures, and housing conditions.
A typical Methods-section statement:
“All animal experiments were performed in accordance with institutional ethical guidelines and were approved by the [Institutional Ethical Committee], approval number: [XXX], dated: [DD/MM/YYYY].”
The approval number and date must be clearly indicated. The journal reserves the right to request supporting documentation during review.
A conflict of interest (COI) arises when an individual’s personal, financial, or professional affiliations have the potential to compromise, or appear to compromise, their objectivity in conducting, reviewing, or publishing scientific research. This applies to authors, reviewers, and editors.
All authors must disclose any actual or potential conflicts of interest, including but not limited to:
A conflict of interest declaration must be included at submission and stated explicitly in the manuscript (in a “Conflicts of Interest” section before the References). Example:
“The authors declare no conflict of interest.”
or
“Author A has received funding from [Company Name]. Author B serves as a consultant for [Organization]. These relationships had no influence on the design, execution, or interpretation of the study.”
Failure to disclose a conflict may result in manuscript rejection, retraction, or other editorial action, depending on severity and intent.
Reviewers and editors must recuse themselves from handling any manuscript in which they:
Editors as authors: If an editor (including the Editor-in-Chief) is an author or co-author on a submission, that manuscript must be handled independently by another editor, from initial screening through final decision, with the author-editor excluded from all editorial correspondence and decision-making regarding their own manuscript.
Reviewers must disclose any potential COI upon invitation and decline if a conflict exists.
All declared conflicts of interest are published alongside the article.
Manuscript submission to jbarbiomed constitutes a commitment to consider the work for publication exclusively in this journal. Withdrawal requests, particularly at advanced stages of processing, consume editorial and peer-review resources and disrupt the editorial workflow, so the following stages apply:
Pre-review withdrawal (within 10 days of submission): Authors may request withdrawal by email from the corresponding author, stating the reason. This will generally be approved.
Withdrawal after peer review has commenced or during revision: Discouraged, given the time invested by editors and reviewers. Withdrawal at this stage may be granted only for ethical violations, submission errors, or institutional mandates, with detailed justification, and is subject to editorial approval.
Withdrawal after acceptance / during production: Withdrawal at this stage is granted only in cases of ethical or legal issues identified after acceptance, and requires Editor-in-Chief approval.
Post-publication (“withdrawal” of a published article): A published article can only be removed or retracted in cases involving copyright violation, ethical misconduct, or legal dispute, following the Retraction and Correction Policy (Section 9) and COPE’s retraction guidance. Retaining copyright as an author does not confer a unilateral right to withdraw or retract a published article.
Fees and consequences: - No fees paid during submission, peer review, or publication are refundable under any withdrawal circumstance. - A processing charge of $100 USD applies to approved withdrawals after peer review has commenced. - Withdrawal requests made in bad faith (e.g., to submit the same work elsewhere after receiving free review feedback, or repeated unjustified withdrawals by the same corresponding author) may result in the journal declining to consider further submissions from that corresponding author for a period of up to 12 months.
To reduce withdrawal risk, before submission the corresponding author should confirm: the accuracy and completeness of all data and analyses; that all permissions for third-party material are obtained and documented; the final author list, order, and contributions; that all co-authors have reviewed and consented to the submission and the target journal; and that the manuscript is not under consideration elsewhere.
All withdrawal requests are subject to editorial approval and review by the editorial board.
jbarbiomed is committed to maintaining the integrity and accuracy of the scholarly record, in accordance with COPE’s retraction guidelines.
Grounds for retraction, following a rigorous editorial investigation:
Retraction notices are clearly linked to the original article, remain permanently accessible, and include a transparent explanation. Authors and their institutions are formally notified.
Erratum: issued when an error was introduced by the journal during production/editing.
Corrigendum: a correction requested by the author(s) to address substantive errors or omissions that may alter the interpretation of the data. All corrigenda require editorial approval and the signature of all contributing authors; further peer review may be applied at the editors’ discretion.
Addendum: supplements the original article with additional data, clarification, or context unintentionally omitted, without contradicting the original conclusions. Subject to editorial review and, where necessary, additional peer assessment.
If authors identify an issue in their published work, the request undergoes secondary review by the Editor-in-Chief, selected Editors, and, where applicable, the original reviewer(s), before publication under the relevant correction category above.
jbarbiomed publishes Special Issues on focused, timely, high-impact topics within its scope: basic and applied biomedical research; translational and experimental medicine; medical biology and disease mechanisms; and diagnostics, therapeutics, and biomedical technologies.
jbarbiomed does not currently carry commercial advertising. If this changes in future, any advertising will be clearly labeled as such, kept separate from editorial content, and will have no influence on editorial decisions, peer review outcomes, or article content.
The names and email addresses entered on this journal’s site are used exclusively for the stated purposes of this journal (manuscript processing, peer review coordination, and journal notifications) and will not be made available for any other purpose or to any other party.
Accepted manuscripts are sent as PDF or MS Word proofs to the corresponding author for typographical correction. Proofs must be returned within 7 days. Articles are published online continuously as soon as they are approved for production, rather than being held for a fixed issue release date.
Title: Journal of Basic and Applied Research in Biomedicine
Abbreviation: J. basic appl. Res. Biomed.
ISSN: 2710-1479
DOI: 10.51152
Country: Jordan
Scope: Broad scope in biomedical sciences
Open access policy: The journal will provide open access to its contents
Copyright notice: CC Attribution 4.0
Archival system: LOCKSS and CLOCKSS
Submission: editor@jbarbiomed.com
Greenfort Organization for Academic Research and Development (House No-225, Barhawar, P.S-Murajhar, Hojai, Assam, India, 782439)
